Atrial Fibrillation
Decision Aide & Guideline References
- Gage BF, van Walraven C, Pearce L, et al. (2004). Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 110 (16): 2287–92.
- Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001). Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285 (22): 2864–70.
- Risk of Stroke with AF. VA Palo Alto Medical Center and at Stanford University: the Sportsmedicine Program and the Cardiomyopathy Clinic. http://www.cardiology.org/tools/risk_of_stroke_AF.html. Retrieved 2007-09-14.
- Steiner, Thorsten; Jonathan Rosand, Michael Diringer (2006). Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. . Stroke 37 (1): 256–62.
- Stuart J. Connolly, M.D., Michael D. Ezekowitz, M.B., Ch.B., D.Phil., Salim Yusuf, F.R.C.P.C., D.Phil.,John Eikelboom, M.D., Jonas Oldgren, M.D., Ph.D., Amit Parekh, M.D., Janice Pogue, M.Sc., Paul A. Reilly, Ph.D.,Ellison Themeles, B.A., Jeanne Varrone, M.D., Susan Wang, Ph.D., Marco Alings, M.D., Ph.D., Denis Xavier, M.D.,Jun Zhu, M.D., Rafael Diaz, M.D., Basil S. Lewis, M.D., Harald Darius, M.D., Hans-Christoph Diener, M.D., Ph.D.,Campbell D. Joyner, M.D., Lars Wallentin, M.D., Ph.D., and the RE-LY Steering Committee and Investigators*. Dabigatran versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med 361:1139-1151.
- Supplement to: Connolly SJ, Ezekowitz MD, Yusuf S, Reilly PA, Wallentin L. Newly identified events in the RE-LY trial. N Engl J Med 2010;363:1875-6.
- Ralph L. Sacco, Robert Adams, Greg Albers, Mark J. Alberts, Oscar Benavente, Karen Furie, Larry B. Goldstein, Philip Gorelick, Jonathan Halperin, Robert Harbaugh, S. Claiborne Johnston, Irene Katzan, Margaret Kelly-Hayes, Edgar J. Kenton, Michael Marks, Lee H. Schwamm and Thomas Tomsick. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke. Stroke 2006;37;577-617.
- The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation. NEJM 2001. Volume 345:494-502.
- Hart RG , Pearce LA , Aguilar MI . Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation . Ann Intern Med. 2007 ; 146 ( 12 ): 857 - 867.
- Gregory Y. H. Lip, Robby Nieuwlaat, Ron Pisters, Deirdre A. Lane and Harry J. G. M. Crijns. Refining Clinical Risk Stratifion for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach : The Euro Heart Survey on Atrial Fibrillation. Chest 2010;137;263-272.
- Gage BF, van Walraven C, Pearce L, et al. (2004). Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 110 (16): 2287–92.
- Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001). Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285 (22): 2864–70.
- Risk of Stroke with AF. VA Palo Alto Medical Center and at Stanford University: the Sportsmedicine Program and the Cardiomyopathy Clinic. http://www.cardiology.org/tools/risk_of_stroke_AF.html. Retrieved 2007-09-14.
- Steiner, Thorsten; Jonathan Rosand, Michael Diringer (2006). Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. . Stroke 37 (1): 256–62.
- Stuart J. Connolly, M.D., Michael D. Ezekowitz, M.B., Ch.B., D.Phil., Salim Yusuf, F.R.C.P.C., D.Phil.,John Eikelboom, M.D., Jonas Oldgren, M.D., Ph.D., Amit Parekh, M.D., Janice Pogue, M.Sc., Paul A. Reilly, Ph.D.,Ellison Themeles, B.A., Jeanne Varrone, M.D., Susan Wang, Ph.D., Marco Alings, M.D., Ph.D., Denis Xavier, M.D.,Jun Zhu, M.D., Rafael Diaz, M.D., Basil S. Lewis, M.D., Harald Darius, M.D., Hans-Christoph Diener, M.D., Ph.D.,Campbell D. Joyner, M.D., Lars Wallentin, M.D., Ph.D., and the RE-LY Steering Committee and Investigators*. Dabigatran versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med 361:1139-1151.
- Ralph L. Sacco, Robert Adams, Greg Albers, Mark J. Alberts, Oscar Benavente, Karen Furie, Larry B. Goldstein, Philip Gorelick, Jonathan Halperin, Robert Harbaugh, S. Claiborne Johnston, Irene Katzan, Margaret Kelly-Hayes, Edgar J. Kenton, Michael Marks, Lee H. Schwamm and Thomas Tomsick. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke. Stroke 2006;37;577-617.
- The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation. NEJM 2001. Volume 345:494-502.
- Hart RG , Pearce LA , Aguilar MI . Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation . Ann Intern Med. 2007 ; 146 ( 12 ): 857 - 867 .
- Gregory Y. H. Lip, Robby Nieuwlaat, Ron Pisters, Deirdre A. Lane and Harry J. G. M. Crijns. Refining Clinical Risk Stratifion for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach : The Euro Heart Survey on Atrial Fibrillation. Chest 2010;137;263-272.
- Canadian Cardiovascular Society 2010 Atrial Fibrillation Guidelines.
|
